Bioactive steroidal alkaloids from Buxus macowanii Oliv
Cheuk W Lam1, Andrew Wakeman2, Abin James2
1Department of Chemistry, Richardson College for the Environmental and Science Complex, The University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada; Department of Chemistry, The University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
This study isolated five new steroidal alkaloids from Buxus macowanii, evaluating their potential as acetylcholinesterase (AChE) inhibitors and BACE1 inhibitors for Alzheimer's disease research.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Buxus macowanii is a plant source of bioactive steroidal alkaloids.
- Steroidal alkaloids are investigated for their therapeutic potential, particularly in neurological disorders.
Purpose of the Study:
- To isolate and characterize novel steroidal alkaloids from Buxus macowanii.
- To evaluate the in vitro inhibitory activities of these compounds against acetylcholinesterase (AChE) and BACE1.
Main Methods:
- Phytochemical investigation using spectroscopic methods (1D/2D NMR, MS).
- Isolation and structure elucidation of ten steroidal alkaloids (five new, five known).
- In vitro enzyme inhibition assays for AChE and BACE1.
Main Results:
- Five new steroidal alkaloids (1-5) and five known steroidal bases (6-10) were identified.
- Compounds 1, 3, and 4 feature a rare Δ(1,2) 9(10→19) abeo triene system.
- All isolates showed moderate to weak in vitro AChE inhibitory activity (IC50: 10.8-98μM).
- Compounds 1 and 6 exhibited moderate BACE1 inhibitory activity.
Conclusions:
- Buxus macowanii yields structurally diverse steroidal alkaloids with potential therapeutic applications.
- The isolated compounds demonstrate inhibitory effects against AChE and BACE1, suggesting neuroprotective properties.
- Further research into these alkaloids could lead to novel treatments for Alzheimer's disease.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
09:36Author Spotlight: Discovering New Alkaloids in Plants with Advanced Mass Spectrometry Techniques
Published on: March 8, 2024
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Drugs that Stabilize Microtubules
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Blockers
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Opioid Receptors: Overview
